An international team of researchers has systematically measured the β-decay half-lives of 40 nuclei near calcium-54, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Beta-blockers did not improve clinical outcomes after ...

Autoantibodies for type 1 diabetes are markers of the immune system’s attack on beta cells. Testing for these autoantibodies – GAD, IA-2, IAA, ZnT8, and ICA – can help with monitoring and preparing ...

New research (the Ver-A-T1D trial) presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) (Vienna, 15-19 September) shows that slow-release (SR) verapamil ...

Madrid, Spain – 30 August 2025 : Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no ...

A panelist discusses how type 1 diabetes (T1D) is a complex autoimmune disease characterized by progressive beta cell destruction that advances through distinct stages, with genetic predisposition, ...

A groundbreaking study led by researchers at the Masonic Medical Research Institute (MMRI) has identified a promising molecular target to protect the heart against damage caused by a high-fat diet and ...

Biomea Fusion, Inc. announced positive results from preclinical experiments showing that its investigational drug icovamenib enhances beta cell function and improves the responsiveness of human islets ...

Amazon Web Services (AWS) has announced it is beta testing X-Ray Recaps. Driven by generative AI, X-Ray Recaps provides personalised summaries of full TV seasons, single episodes and individual ...